Position in VCYT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,472,885
-$96,184 QoQ
Shares Held
42,106
-47.2% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#120
of 367 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VCYT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026MOORE CAPITAL MANAGEMENT, LP holds $26,857,848 across 9 Diagnostics & Research names. VCYT ranks #5 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IQV |
Iqvia Holdings Inc.
|
55,756 | $10,773,174 | |
| 2 | SHC |
Sotera Health Co
|
213,946 | $3,797,541 | |
| 3 | ICLR |
Icon PLC
|
19,382 | $3,366,847 | |
| 4 | DHR |
Danaher Corp /De/
|
16,927 | $3,224,254 | |
| 5 | VCYT |
Veracyte, Inc.
This page
|
42,106 | $2,472,885 | |
| 6 | MYGN |
Myriad Genetics Inc
|
188,526 | $1,076,483 | |
| 7 | FLGT |
Fulgent Genetics, Inc.
|
48,343 | $991,998 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
3,892 | $882,666 |
All Filings in VCYT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,472,885 | 42,106 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,569,069 | 79,760 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,800,406 | 42,765 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||